Sponsor study identifier
NIH
interventional
80
1 country
1
Study Start
January 2001
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2001
Actual (reported)Study Completion
April 2003
Actual (reported)The objective of the present investigation is to analyze EEG and auditory evoked potentials at the transition from consciousness to unconsciousness and vice versa. A set of electroencephalographic and auditory evoked potential parameters should be identified that allows separation of consciousness from unconsciousness (reflected by responsiveness/unresponsiveness to command). The study is based on data of 80 patients undergoing general anesthesia with remifentanil and either sevoflurane or propofol.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2003
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2001
Date type not reportedThis date has not been verified as actual or estimated.
November 2001
Actual (reported)April 2003
Actual (reported)October 29, 2012
Actual (reported)November 2, 2012
Actual (reported)Changes in EEG- and AEP-parameters during loss- and return of consciousness
1 day
Impact of muscle activity on EEG- and AEP-parameters
1 day
Influence of anesthetics on EEG- and AEP-parameters
1 day
General anesthesia
General anesthesia: Loss of consciousness and standard clinical practice
General anesthesia: Loss of consciousness and standard clinical practice
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Grouped treatment entry
Propofol / Remifentanil
The registry names several treatments. This does not confirm that participants received them together or that they form a single product.
View registry recordGrouped treatment entry
Sevoflurane / Remifentanil
The registry names several treatments. This does not confirm that participants received them together or that they form a single product.
View registry recordTechnische Universität München, Klinikum rechts der Isar, Department of Anesthesiology
Munich, Bavaria, Germany
Eberhard F Kochs, MD
Technical University of Munich
80 participants (actual enrollment reported by the registry).
First Submitted
October 29, 2012
First Posted
November 2, 2012
Study Start
January 2001
Date type not reportedThis date has not been verified as actual or estimated.
Recovery Effect of Sugammadex Measured by Bispectral and Neurosense Indices
Contact the study team to confirm eligibility.
Primary Completion
November 2001
Actual (reported)Study Completion
April 2003
Actual (reported)Last Updated
November 2, 2012
Record last verified: 2012-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: